Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/539
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSinclair, Rodney-
dc.contributor.otherHarries, M. J.-
dc.contributor.otherTosti, A.-
dc.contributor.otherBergfeld, W.-
dc.contributor.otherBlume-Peytavi, U.-
dc.contributor.otherShapiro, Jeremy-
dc.contributor.otherLutz, G.-
dc.contributor.otherMessenger, A.-
dc.contributor.otherPaus, R.-
dc.date.accessioned2016-02-18T01:48:09Z-
dc.date.available2016-02-18T01:48:09Z-
dc.date.issued2015-12-
dc.identifier.citationJ Eur Acad Dermatol Venereol. 2015 Dec 17.en_US
dc.identifier.issn0926-9959en_US
dc.identifier.issn1468-3083en_US
dc.identifier.urihttp://hdl.handle.net/11434/539-
dc.description.abstractBACKGROUND: Female pattern hair loss (FPHL) is a common non-scarring alopecia characterized by widening of the midline hair part at the crown (vertex). In 1977, Ludwig developed a scale that graded the degree of visible vertex hair thinning from I (least severe) to III (most severe). However, by the time patients exhibit the full manifestations of 'Ludwig I', they have already lost a significant volume of hair. Although current therapies may realistically halt progression of hair loss, improvements in hair density is often more limited. Identification and grading of FPHL at an earlier stage is desirable to institute appropriate therapy before significant hair loss has occurred and to enable monitoring over time. AIM: To generate consensus guidance for the recognition and quantification of FPHL that can be used in the clinic. METHODS: Nine clinicians from Europe, North America and Australia experienced in the management of FPHL developed this scale by consensus. RESULTS: We propose a three-point severity scale (termed the FPHL Severity Index (FPHL-SI)) that combines validated measures of hair shedding, midline hair density and scalp trichoscopy criteria to produce a total FPHL-SI score (maximum score = 20). The score is designed to grade FPHL severity over time, while being sufficiently sensitive to identify early disease. A score of 0-4 makes FPHL unlikely; a score of 5-9 would indicate early-stage FPHL, with higher scores indicating greater disease severity. CONCLUSIONS: As a starting point for further public debate, we employ criteria already used in clinical practice to generate a pragmatic FPHL grading system (FPHL-SI) of sufficient sensitivity to identify and monitor early FPHL changes. This may have to be further optimized after systematic validation in clinical practice.en_US
dc.publisherWileyen_US
dc.subjectFemale Pattern Hair Lossen_US
dc.subjectSeverity Indexen_US
dc.subjectAlopeciaen_US
dc.subjectFPHL-SIen_US
dc.subjectThree Point Severity Scaleen_US
dc.subjectHair Densityen_US
dc.subjectDisease Severityen_US
dc.subjectEarly Diseaseen_US
dc.subjectLudwig Scaleen_US
dc.subjectHead & Neck Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.subjectEpworth HealthCare, Richmond, Victoria, Australia, Victoria, Australiaen_US
dc.titleTowards a consensus on how to diagnose and quantify female pattern hair loss - The Female Pattern Hair Loss Severity Index (FPHL-SI).en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1111/jdv.13455en_US
dc.identifier.journaltitleJournal of the European Academy of Dermatology and Venereologyen_US
dc.description.pubmedurihttp://www.ncbi.nlm.nih.gov/pubmed/26676524en_US
dc.description.affiliatesSalford Royal NHS Foundation Trust, The University of Manchester, Manchester, UKen_US
dc.description.affiliatesUniversity of Miami, Miami, FL, USAen_US
dc.description.affiliatesUniversity of Bologna, Bologna, Italyen_US
dc.description.affiliatesCleveland Clinic, Cleveland, OH, USAen_US
dc.description.affiliatesCharité University of Berlin, Berlin, Germanyen_US
dc.description.affiliatesUniversity of British Columbia, Vancouver, Germanyen_US
dc.description.affiliatesNew York University, New York, NY, USAen_US
dc.description.affiliatesHair and Nail, Bonn, Germanyen_US
dc.description.affiliatesRoyal Hallamshire Hospital, University of Sheffield, Sheffield, UKen_US
dc.description.affiliatesUniversity of Melbourne, Melbourne, Australiaen_US
dc.description.affiliatesUniversity of Manchester, Manchester, UKen_US
dc.description.affiliatesUniversity of Münster, Münster, Germanyen_US
dc.type.studyortrialProspective Studyen_US
dc.type.contenttypeTexten_US
Appears in Collections:Dermatology
Head & Neck

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.